In January 2022, TCROSS Co., Ltd. launched a clinical research support service for doctors seeking to build evidence by addressing issues in clinical practice in Japan and verifying the safety and efficacy of diagnoses and treatments.
Clinical Research Support Services - Asking the Investigator of the EPOCH Study
TCROSS asked Dr. Keisuke Hirano of the Toyohashi Heart Center, who is conducting a clinical study using this service, about the ongoing EVUS guided wiring vs. knuckle wiring for femoropopliteal chronic total occlusive lesion (EPOCH) study as well as his experience in the field.
What are some of the challenges in the progression of clinical research initiated by doctors?
I have participated in and conducted many clinical studies, and the biggest challenge has been raising the cost of core lab analysis requests whilst maintaining the morale of the investigators.
No matter how much clinically valuable research we try to conduct, without the cooperation of companies, doctors, and other supporting organizations and institutions, it is difficult to carry out our ideal research.
TCROSS also has an operational system for carrying out clinical research initiated by doctors and a mechanism for connecting investigators who participate in the studies, as well as an information dissemination system already in place. What we’re conducting here with EPOCH is a prospective, investigator-initiated clinical study. and we are pleased to have the support of TCROSS in this regard.
The company's expertise in the field of catheterization has the advantage of allowing us to carry out our research without delay because of their understanding of the techniques and device evaluation, making them an encouraging ally in supporting our activities.
I understand that the system is still in its infancy, but together we hope to disseminate valuable research to actual clinical practice in Japan.
What is the EPOCH study?
This study is a core-laboratory analysis of IVUS data from patients who underwent body surface echo wiring and knuckle wiring for EVT in CTO lesions with the aim of comparing the chronic phase results of intraplaque angioplasty and subintimal angioplasty. This is a long-term follow-up study of the therapeutic effects of angioplasty. It is unprecedented in the world, and we believe it will provide a lot of useful information for actual clinical practice going forward.
We hope to report on our activities and interim results through the EPOCH study website in the future.
We will do our best to publish our research results in the form of an academic paper and hope to meet the expectations of the companies and institutions that have endorsed this research.
※コンテンツには、国内で未承認、適応外の医療機器、医薬品、または効能・効果/用法・用量の情報を含む場合がありますが、未承認、適応外の使用を推奨するものではありません。
ご注意 当サイト内の全ての記事と動画の転載・転送はご遠慮ください。なお、法律上保護されたコンテンツの無許可の転載、複製、転用等は、当該コンテンツの権利者等から損害賠償請求その他の法的手続を申し立てられ、事案によっては処罰される可能性、また、故意にそれらを受け取った場合も同様の措置を受ける可能性がございます。ご不明な点がございましたら当社までご連絡ください。
おすすめ
